9amHealth Raises $26M to Expand Into Chronic Conditions Driving the Majority of Employer Pharmacy Spend
Summary
9amHealth raised $26 million in a Series B round led by Define Ventures to expand its AI-driven virtual specialty care platform beyond cardiometabolic care. The company has generated more than $50M in projected medical and pharmacy savings across two Fortune 100 employers and now plans to address additional high-cost chronic conditions that drive up to 70% of employer pharmacy spend. The funding will support scaling clinical infrastructure, AI-enabled workflows, and care delivery to manage specialty-level chronic conditions at scale. Define Ventures' Lynne O'Keefe will join 9amHealth's board as the company partners with employers, health plans, and PBMs to deliver integrated care and medication management.
Funding
Amount
$26.0M
Total raised
Date
May 13, 2026
Announcement date
Investors
Define Ventures, 7wire Ventures
Lead investors
Company
9am.health
Funded company
Classifications
industries
HealthTech
applications
Data Warehousing Software
AskAI Classifications
Labels
No AI classifications detected